Business Development Our Business Development Team has made California Clinical Trials one of the largest, most popular drug research facilities in the country. Backed by a track record of unsurpassed performance and quality results for our Sponsors, CCT delivers. Contact any one of our executives below to find out how CCT can help accelerate your drug development process at one of our world-class hospital-based sites. |
EARLY DRUG DEVELOPMENT (EDD), CNS PHASE II-IV, SLEEP CLINICAL DEVELOPMENT SERVICES, |
 |
| Early Drug Development (EDD) and Experimental Medicine studies can compare the target patient population across the array of CNS disorders with healthy volunteer subjects. Unique to CCT, these studies are performed at our Phase I unit at Glendale Adventist Medical Center with competitive value driven pricing. We are leaders in strategies to accelerate global drug development, including ethnobridging studies. Phase I studies can be designed to provide data acceptable to both Japanese and Western countries' regulatory agencies. |
||||||
 |
 |
 |
||||
| Larry Ereshefsky, Pharm. D., F.C.C.P, B.C.P.P Chief Scientific Officer & Psychiatry Therapeutic Expert  Larry.Ereshefsky@cctrials.com 818.254.1650 |
Stanford Jhee, Pharm. D Senior Director of Research Stan.Jhee@cctrials.com 818.254.1612 |
Samira Moran, B.S. Senior Director, Unit Head Samira.Moran@cctrials.com 818.254.1686 |
||||
|
||||||
